Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

545
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
545
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

371
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
371
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.3K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.3K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

349
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
349
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

557
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
557
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

627
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
Same author

Comment on: Relevance of isolated IgM antiphospholipid antibodies in a longitudinal cohort of antiphospholipid syndrome: reply.

Rheumatology (Oxford, England)·2026
Same author

Hydroxychloroquine and teratogenic risk in pregnancy in systemic autoimmune diseases: A systematic narrative review.

Autoimmunity reviews·2026
Same author

Relevance of isolated IgM antiphospholipid antibodies in a longitudinal cohort of antiphospholipid syndrome.

Rheumatology (Oxford, England)·2026
Same author

Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Abnormal soluble fms-like tyrosine kinase to placental growth factor ratio during pregnancy and subjective memory impairment 3 to 6 years postpartum.

American journal of obstetrics and gynecology·2026

Related Experiment Video

Updated: Apr 17, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

4.1K

Recurrent miscarriage: causes, evaluation and management.

Carmen Garrido-Gimenez1, Jaume Alijotas-Reig2

  • 1High Obstetric Risk Unit, Obstetric Department, Vall d'Hebrón University Hospital, Universitat Autónoma, Barcelona, Spain.

Postgraduate Medical Journal
|February 15, 2015
PubMed
Summary

Recurrent miscarriage affects 5% of couples, with unknown causes in half of cases. Emerging immunological insights and targeted treatments offer hope for improved pregnancy outcomes.

Keywords:
FETAL-MATERNAL TOLERANCERECURRENT MISCARRIAGERECURRENT PREGNANCY LOSS

More Related Videos

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
07:46

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

2.0K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 17, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

4.1K
Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
07:46

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

2.0K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.4K

Area of Science:

  • Reproductive Immunology
  • Obstetrics
  • Genetics

Background:

  • Recurrent miscarriage (RM) impacts 5% of couples, often with unidentified causes.
  • Known RM etiologies include chromosomal, endocrine, and uterine factors.
  • The role of alloimmune mechanisms in RM requires further elucidation.

Purpose of the Study:

  • To review current understanding and emerging concepts in recurrent miscarriage.
  • To explore novel immunological factors and diagnostic/therapeutic strategies for RM.
  • To assess the utility of genetic screening and the effectiveness of treatments for RM.

Main Methods:

  • Literature review of immunological mechanisms in recurrent miscarriage.
  • Analysis of novel biomarkers and their potential clinical application.
  • Evaluation of current and emerging therapeutic interventions for RM.

Main Results:

  • Alloimmune mechanisms, including natural killer cells and cytokines, are increasingly implicated in RM.
  • Established treatments for antiphospholipid syndrome and endocrine disorders improve outcomes.
  • New therapeutic approaches show promise for enhancing fetal-maternal outcomes.

Conclusions:

  • Understanding RM etiology is advancing with new immunological insights.
  • Personalized treatment strategies are crucial for managing recurrent miscarriage.
  • Continued research into novel therapies is essential for improving reproductive success.